Primary Sjögren syndrome in Han Chinese: Clinical and immunological characteristics of 483 patients

Medicine (United States)

Volumn 94, Issue 16, 2015, Pages

  Zhao, Yun ^a   Li, Ya ^a   Wang, Li ^a   Li, Xiao Feng ^b   Huang, Ci Bo ^c   Wang, Guo Chun ^d   Zhang, Xue Wu ^e   Zhang, Zhuo Li ^e   Zhang, Xiao ^f   Xiao, Wei Guo ^g   Dai, Lie ^h   Wang, Yong Fu ⁱ   Hu, Shao Xian ^j   Li, Hong Bin ^k   Gong, Lu ^l   Liu, Bin ^m   Sun, Ling Yun ⁿ   Zhang, Miao Jia ^o   Zhang, Xuan ^a   Li, Yong Zhe ^a   Du, De Shun ^a   Zhang, Shun Hua ^a   Sun, Yuan Yuan ^a   Zhang, Feng Chun ^a   more..

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

^c BEIJING HOSPITAL   (China)

^d CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^e PEKING UNIVERSITY FIRST HOSPITAL   (China)

^f GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

^g CHINA MEDICAL UNIVERSITY   (China)

^h SUN YAT SEN UNIVERSITY   (China)

ⁱ BAOTOU MEDICAL COLLEGE   (China)

^j HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^k INNER MONGOLIA MEDICAL COLLEGE   (China)

^l TIANJIN MEDICAL UNIVERSITY   (China)

^m QINGDAO UNIVERSITY   (China)

ⁿ MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^o THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTEIN; RHEUMATOID FACTOR;

ADULT; ARTHRITIS; ARTICLE; ATRIOVENTRICULAR BLOCK; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CLINICAL FEATURE; COMPLEMENT BLOOD LEVEL; ERYTHROCYTE SEDIMENTATION RATE; EXOCRINE GLAND; FEMALE; FLACCID PARALYSIS; HAN CHINESE; HUMAN; HYPOCOMPLEMENTEMIA; HYPOKALEMIA; IMMUNOGLOBULIN BLOOD LEVEL; INTERSTITIAL LUNG DISEASE; KIDNEY CALCIFICATION; KIDNEY INJURY; KIDNEY TUBULE ACIDOSIS; LACRIMAL GLAND DISEASE; LEUKOPENIA; LUNG BULLA; LUNG DISEASE; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEPHROLITHIASIS; ONSET AGE; PANCYTOPENIA; PAROTID ENLARGEMENT; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PULMONARY HYPERTENSION; PURPURA; SALIVARY GLAND DISEASE; SJOEGREN SYNDROME; SPLENOMEGALY; SYSTEMIC DISEASE; XEROPHTHALMIA; AGE; CHINA; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; IMMUNOLOGY; PATHOPHYSIOLOGY;

ADULT; AGE FACTORS; AGE OF ONSET; ANTIBODIES, ANTINUCLEAR; CHINA; ETHNIC GROUPS; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; RHEUMATOID FACTOR; SJOGREN'S SYNDROME;

EID: 84929658868     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000667     Document Type: Article

References (47)

1. Malladi AS, Sack KE, Shiboski S, et al. Primary Sjögren's syndrome as a systemic disease: a study of participants enrolled in an international Sjogren's syndrome registry. Arthritis Care Res. 2012;64:911-918.
2. Ramos-Casals M, Brito-Zerón P, Sisó-Almirall A, et al. Primary Sjögren syndrome. BMJ. 2012;344:e3821.
3. Voulgarelis M, Ziakas PD, Papageorgiou A, et al. Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren's syndrome. Medicine. 2012;91:1-9.
4. Zhang NZ, Shi CS, Yao QP, et al. Prevalence of primary Sjogren's syndrome in China. J Rheumatol. 1995;22:659-661.
5. Birlik M, Akar S, Gurler O, et al. Prevalence of primary Sjogren's syndrome in Turkey: a population-based epidemiological study. Int J Clin Pract. 2009;63:954-961.
6. Anagnostopoulos I, Zinzaras E, Alexiou I, et al. The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord. 2010;11:98.
7. Daniels TE, Aufdemorte TB, Greenspan JS. Histopathology of Sjogren's syndrome. In: Talal MH, Kassan SS, eds. Sjogren's Syndrome: Clinical and Immunological Aspects. Berlin: Springer; 1987:266-286.
8. Brito-Zero'n P, Ramos-Casals M, Bove A, et al. Predicting adverse outcomes in primary Sjogren's syndrome: identification of prognostic factors. Rheumatology. 2007;46:1359-1362.
9. Jonsson R, Bolstad AI, Brokstad KA, et al. Sjogren's syndrome-a plethora of clinical and immunological phenotypes with a complex genetic background. Ann N Y Acad Sci. 2007;1108:433-447.
10. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjogren syndrome. Arch Intern Med. 2004;164:1275-1284.
11. Fox R. Sjogren's syndrome. Lancet. 2005;366:321-331.
12. Haga H, Jonsson R. The influence of age on disease manifestations and serological characteristics in primary Sjogren's syndrome. Scand J Rheumatol. 1999;28:227-232.
13. Manuel RC, Roser S, Jose R, et al. Primary Sjogren Syndrome in Spain: Clinical and Immunologic Expression in 1010 Patients. Medicine. 2008;87:210-219.
14. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554-558.
15. Yongzhe Li, Kunlin Zhang, Hua Chen, et al. A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23. Nature Ge Netics. 2013;45:1361-1365.
16. Skopouli FN, Dafni U, Ioannidis JP, et al. Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome. Semin Arthritis Rheum. 2000;29:296-304.
17. Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sjogren's syndrome. Autoimmun Rev. 2010;9:A305-310.
18. Anaya J, Liu G, D'Souza E, et al. Primary Sjogren's syndrome in men. Ann Rheum Dis. 1995;54:748-751.
19. Asmussen K, Andersen V, Bendixen G, et al. A new model for classification of disease manifestations in primary Sjogren's syndrome: evaluation in a retrospective long-term study. J Intern Med. 1996;239:475-482.
20. Brennan M, Sankar V, Leakan R, et al. Risk factors for positive minor salivary gland biopsy findings in Sjogren's syndrome and dry mouth patients. Arthritis Rheum. 2002;47:189-195.
21. Cervera R, Font J, Ramos-Casals M, et al. Primary Sjogren's syndrome in men: clinical and immunological characteristics. Lupus. 2000;9:61-64.
22. Drosos A, Tsiakou E, Tsifetaki N, et al. Subgroups of primary Sjogren's syndrome: Sjogren's syndrome in male and paediatric Greek patients. Ann Rheum Dis. 1997;56:333-335.
23. Molina R, Provost T, Arnett F, et al. Primary Sjogren's syndrome in men. Clinical, serologic, and immunogenetic features. Am J Med. 1986;80:23-31.
24. Saito T, Sato J, Kondo K, et al. Low prevalence of clinicopathologic and sialographic changes in salivary glands of men with Sjogren's syndrome. J Oral Pathol Med. 1999;28:312-316.
25. Bartunkova J, Sediva A, Vencovsky J, et al. Primary Sjogren's syndrome in children and adolescents: proposal for diagnostic criteria. Clin Exp Rheumatol. 1999;17:381-386.
26. Farah S, Ronald PR, Frank CA, et al. Association of labial salivary gland histopathology with clinical and serologic features of connective tissue diseases. Arthritis Rheum. 1990;33:1682-1687.
27. Isao I, Sonoko N, Masanori K, et al. Pulmonary Manifestations of Primary Sjogren's Syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med. 2005;171:632-638.
28. Shi JH, Liu HR, Xu WB, et al. Pulmonary manifestations of Sjogren's syndrome. Respiration. 2009;78:377-386.
29. Yazisiz V, Arslan G, Ozbudak IH, et al. Lung involvement in patients with primary Sjögren's syndrome: what are the predictors? Rheumatol Int. 2010;30:1317-1324.
30. Vitali C, Bombardieri S, Moutsopoulos HM, et al. Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993;36:340-347.
31. Wise C, Woodruff R. Minor salivary gland biopsies in patients investigated for primary Sjogren's syndrome. A review of 187 patients. J Rheumatol. 1993;20:1515-1518.
32. Shiboski SC, Shiboski CH, Criswell L, et al. New classification criteria for Sjögren's Syndrome: a data-driven expert-clinician consensus approach within the SICCA Cohort. Arthritis Care Res. 2012;64:475-487.
33. Routsias JG, Tzioufas AG. Sjögren's syndrome-study of autoantigens and autoantibodies. Clin Rev Allergy Immunol. 2007;32:238-251.
34. Alexander E, Arnett F, Provost T, et al. Sjogren's syndrome:association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med. 1983;98:155-159.
35. Alexander E, Provost T, Stevens M, et al. Neurologic complications of primary Sjogren's syndrome. Medicine (Baltimore). 1982;61: 247-257.
36. Davidson B, Kelly C, Griffiths I. Primary Sjogren's syndrome in the North East of England: a long-term follow-up study. Rheumatology (Oxford). 1999;38:245-253.
37. Harley J, Alexander E, Bias W, et al. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjogren's syndrome. Arthritis Rheum. 1986;29:196-206.
38. Moutsopoulos H, Zerva L. Anti-Ro (SSA)/La (SSB) antibodies and Sjogren's syndrome. Clin Rheumatol. 1990;9(1 Suppl 1):123-130.
39. Manoussakis M, Tzioufas A, Pange P, et al. Serological profiles in subgroups of patients with Sjogren's syndrome. Scand J Rheumatol. 1986;Suppl61:89-92.
40. Markusse H, Veldhoven C, Swaak A, et al. The clinical significance of the detection of anti-Ro/SS-A and anti-La/SS-B autoantibodies using purified recombinant proteins in primary Sjogren's syndrome. Rheumatol Int. 1993;13:147-150.
41. Kang K, Kim H, Kwok S, et al. Impact of interleukin-21 in the pathogenesis of primary Sjogren's syndrome: increased serum levels of interleukin-21 and its expression in the labial salivary glands. Arthritis Res Ther. 2011;13:R179.
42. Theander E, Manthorpe R, Jacobsson L. Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study. Arthritis Rheum. 2004;50:1262-1269.
43. Ramos-Casals M, Brito-Zeron P, Yague J, et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome. Rheumatology. 2005;44:89-94.
44. Ioannidis J, Vassiliou V, Moutsopoulos H. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum. 2002;46:741-747.
45. Alamanos Y, Tsifetaki N, Voulgari PV, et al. Epidemiology of primary Sjogren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford). 2006;45:187-191.
46. Garcia-Carrasco M, Ramos-Casals M, Rosas J, et al. Primary Sjogren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81:270-280.
47. Yan SM, Zhang W, LI MT, et al. The clinical characteristics of 573 cases of primary sjogren's syndrome. Chin J Rheumatol. 2010;14:223-227.